Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An International, Multicentre, Prospective, Non-interventional Observational Registry for Patients With X-Linked Hypophosphatemia (XLH)

NCT03193476 is registered in ClinicalTrials.gov with Kyowa Kirin Pharmaceutical Development Ltd as lead sponsor.

NCT NCT03193476
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03193476 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An International, Multicentre, Prospective, Non-interventional Observational Registry for Patients With X-Linked Hypophosphatemia (XLH)
Lead sponsor
Kyowa Kirin Pharmaceutical Development Ltd
Phase
Observational
Overall status
Recruiting
Start date
September 12, 2017
Completion date
July 1, 2029
Enrollment
1,489 (estimated)
Sites
118

Conditions

As the registry lists them; a condition with its own page is linked.

x-linked hypophosphatemia